Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.

Eisenhofer G, Pacak K, Huynh TT, Qin N, Bratslavsky G, Linehan WM, Mannelli M, Friberg P, Grebe SK, Timmers HJ, Bornstein SR, Lenders JW.

Endocr Relat Cancer. 2010 Dec 21;18(1):97-111. doi: 10.1677/ERC-10-0211. Print 2011 Feb.

PMID:
21051559
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location.

Eisenhofer G, Timmers HJ, Lenders JW, Bornstein SR, Tiebel O, Mannelli M, King KS, Vocke CD, Linehan WM, Bratslavsky G, Pacak K.

J Clin Endocrinol Metab. 2011 Feb;96(2):375-84. doi: 10.1210/jc.2010-1588. Epub 2010 Dec 8.

PMID:
21147885
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.

Huynh TT, Pacak K, Brouwers FM, Abu-Asab MS, Worrell RA, Walther MM, Elkahloun AG, Goldstein DS, Cleary S, Eisenhofer G.

Eur J Endocrinol. 2005 Oct;153(4):551-63.

PMID:
16189177
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Urinary free (unconjugated) metadrenalines in different hereditary forms of catecholamine-secreting phaeochromocytoma/paraganglioma.

Davidson DF, Bradshaw N, Perry CG, Lindsay R, Freel EM.

Ann Clin Biochem. 2012 Sep;49(Pt 5):486-90. doi: 10.1258/acb.2012.012021. Epub 2012 Aug 22.

PMID:
22914444
[PubMed - indexed for MEDLINE]
5.

No correlation between phaeochromocytoma catecholamine secretion and granule ultrastructure.

Mihai R, Wong NA, Luckett M, Sheffield E, Farndon JR.

Br J Surg. 1998 Dec;85(12):1681-5.

PMID:
9876074
[PubMed - indexed for MEDLINE]
6.

Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours.

Srirangalingam U, Khoo B, Walker L, MacDonald F, Skelly RH, George E, Spooner D, Johnston LB, Monson JP, Grossman AB, Drake WM, Akker SA, Pollard PJ, Plowman N, Avril N, Berney DM, Burrin JM, Reznek RH, Kumar VK, Maher ER, Chew SL.

Endocr Relat Cancer. 2009 Jun;16(2):515-25. doi: 10.1677/ERC-08-0239. Epub 2009 Feb 10.

PMID:
19208735
[PubMed - indexed for MEDLINE]
Free Article
7.

Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma.

Eisenhofer G, Huynh TT, Elkahloun A, Morris JC, Bratslavsky G, Linehan WM, Zhuang Z, Balgley BM, Lee CS, Mannelli M, Lenders JW, Bornstein SR, Pacak K.

Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1223-33. doi: 10.1152/ajpendo.90591.2008. Epub 2008 Oct 14.

PMID:
18854424
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Chromogranin a expression in phaeochromocytomas associated with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.

Cleary S, Phillips JK, Huynh TT, Pacak K, Fliedner S, Elkahloun AG, Munson P, Worrell RA, Eisenhofer G.

Horm Metab Res. 2007 Dec;39(12):876-83. Epub 2007 Nov 28.

PMID:
18046660
[PubMed - indexed for MEDLINE]
9.

Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.

Eisenhofer G, Lenders JW, Timmers H, Mannelli M, Grebe SK, Hofbauer LC, Bornstein SR, Tiebel O, Adams K, Bratslavsky G, Linehan WM, Pacak K.

Clin Chem. 2011 Mar;57(3):411-20. doi: 10.1373/clinchem.2010.153320. Epub 2011 Jan 24.

PMID:
21262951
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma.

Peitzsch M, Prejbisz A, Kroiß M, Beuschlein F, Arlt W, Januszewicz A, Siegert G, Eisenhofer G.

Ann Clin Biochem. 2013 Mar;50(Pt 2):147-55. doi: 10.1258/acb.2012.012112.

PMID:
23512172
[PubMed - indexed for MEDLINE]
11.

Neuropeptide Y expression in phaeochromocytomas: relative absence in tumours from patients with von Hippel-Lindau syndrome.

Cleary S, Phillips JK, Huynh TT, Pacak K, Elkahloun AG, Barb J, Worrell RA, Goldstein DS, Eisenhofer G.

J Endocrinol. 2007 May;193(2):225-33.

PMID:
17470513
[PubMed - indexed for MEDLINE]
Free Article
12.

Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.

Eisenhofer G, Walther MM, Huynh TT, Li ST, Bornstein SR, Vortmeyer A, Mannelli M, Goldstein DS, Linehan WM, Lenders JW, Pacak K.

J Clin Endocrinol Metab. 2001 May;86(5):1999-2008.

PMID:
11344198
[PubMed - indexed for MEDLINE]
13.

An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.

van Nederveen FH, Gaal J, Favier J, Korpershoek E, Oldenburg RA, de Bruyn EM, Sleddens HF, Derkx P, Rivière J, Dannenberg H, Petri BJ, Komminoth P, Pacak K, Hop WC, Pollard PJ, Mannelli M, Bayley JP, Perren A, Niemann S, Verhofstad AA, de Bruïne AP, Maher ER, Tissier F, Méatchi T, Badoual C, Bertherat J, Amar L, Alataki D, Van Marck E, Ferrau F, François J, de Herder WW, Peeters MP, van Linge A, Lenders JW, Gimenez-Roqueplo AP, de Krijger RR, Dinjens WN.

Lancet Oncol. 2009 Aug;10(8):764-71. doi: 10.1016/S1470-2045(09)70164-0. Epub 2009 Jul 1.

PMID:
19576851
[PubMed - indexed for MEDLINE]
14.

Genetic screening for von Hippel-Lindau gene mutations in non-syndromic pheochromocytoma: low prevalence and false-positives or misdiagnosis indicate a need for caution.

Eisenhofer G, Vocke CD, Elkahloun A, Huynh TT, Prodanov T, Lenders JW, Timmers HJ, Benhammou JN, Linehan WM, Pacak K.

Horm Metab Res. 2012 May;44(5):343-8. doi: 10.1055/s-0032-1304662. Epub 2012 Mar 21.

PMID:
22438210
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.

Eisenhofer G, Lenders JW, Siegert G, Bornstein SR, Friberg P, Milosevic D, Mannelli M, Linehan WM, Adams K, Timmers HJ, Pacak K.

Eur J Cancer. 2012 Jul;48(11):1739-49. doi: 10.1016/j.ejca.2011.07.016. Epub 2011 Oct 28.

PMID:
22036874
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Subclinical phaeochromocytoma.

Mannelli M, Lenders JW, Pacak K, Parenti G, Eisenhofer G.

Best Pract Res Clin Endocrinol Metab. 2012 Aug;26(4):507-15. doi: 10.1016/j.beem.2011.10.008. Epub 2012 May 22. Review.

PMID:
22863392
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Phaeochromocytoma: a catecholamine and oxidative stress disorder.

Pacak K.

Endocr Regul. 2011 Apr;45(2):65-90.

PMID:
21615192
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paraganglioma.

Rao JU, Engelke UF, Rodenburg RJ, Wevers RA, Pacak K, Eisenhofer G, Qin N, Kusters B, Goudswaard AG, Lenders JW, Hermus AR, Mensenkamp AR, Kunst HP, Sweep FC, Timmers HJ.

Clin Cancer Res. 2013 Jul 15;19(14):3787-95. doi: 10.1158/1078-0432.CCR-12-3922. Epub 2013 May 30.

PMID:
23723300
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Clinical and biochemical features of sporadic and hereditary phaeochromocytomas: an analysis of 41 cases investigated in a single endocrine centre.

Patócs A, Karádi E, Tóth M, Varga I, Szücs N, Balogh K, Majnik J, Gláz E, Rácz K.

Eur J Cancer Prev. 2004 Oct;13(5):403-9.

PMID:
15452453
[PubMed - indexed for MEDLINE]
20.

Urinary catecholamines and the diagnosis of phaeochromocytoma in Auckland.

McNeil AR, Woollard GA.

N Z Med J. 1997 Sep 12;110(1051):331-3.

PMID:
9323371
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk